Mirago S 25 Tablet ER
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Mirabegron (25mg) + Solifenacin (5mg)
Overview Mirago S 25 Tablet ER
Mirago S 25 Extended-Release tablets combine two active ingredients to manage overactive bladder symptoms. This medication provides relief from urinary urgency, frequency, and incontinence. Always follow your physician's instructions regarding dosage and treatment duration. Mirago S 25 ER can be taken with or without food, ideally at the same time daily. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Potential side effects include elevated blood pressure, upper respiratory infection (affecting nose and throat), urinary tract infection, and headache. Report any persistent or troublesome side effects to your doctor promptly. Before starting treatment, disclose all other medications and any existing health conditions, including pregnancy or breastfeeding. Patients with liver or kidney impairment should exercise caution and adhere to scheduled follow-up appointments as directed by their doctor.
Primary Ingredients of Mirago S 25 Tablet ER
No text provided. Please provide the text you wish me to rephrase.
Uses of Mirago S 25 Tablet ER
Bladder control issues indicative of OAB
Major Benefits of Mirago S 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Mirago S 25 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Mirago S 25 Tablet ER:
- High blood pressure
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Dryness in mouth
- Constipation
- Increased heart rate
- Blurred vision
How to use Mirago S 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Mirago S 25 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This extended-release medication can be administered with or without food, although consistent timing is recommended.
How Mirago S 25 Tablet ER works:
Mirago S 25 Extended-Release tablets contain Mirabegron and Solifenacin, two medications that synergistically manage urinary symptoms. Mirabegron, a beta-3 adrenergic agonist, relaxes bladder muscles by stimulating specific bladder receptors. Solifenacin, an antimuscarinic agent, similarly promotes bladder muscle relaxation. This dual action reduces urinary frequency, urgency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Mirago S 25 Tablet ER with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Data on Mirago S 25 Tablet ER use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Mirago S 25 Tablet ER use while breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Mirago S 25 Tablet ER on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Mirago S 25 Tablet ER's efficacy and safety in individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data regarding Mirago S 25 Tablet ER use in individuals with hepatic impairment is scarce. Seek medical advice from your physician.
What if you forget to take Mirago S 25 Tablet ER :
NA
Facts to Know About Mirago S 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Urology |
3,018 People bought this recently